Céline Rodriguez - Concepedia

Author

Céline Rodriguez

Inserm ORCID

Also Known As

C Rodriguez, C.A. Rodriguez, C.A. Rodríguez, Celine Rodriguez, Céline Rodriguez, Rodriguez, Céline

Publications

958

Citations

H-Index

Concepts

All Affiliations

Inserm Centre de Recherche en Cancérologie de Lyon Centre National de la Recherche Scientifique Université Claude Bernard Lyon 1 Centre Léon Bérard

About

Céline Rodriguez is an author at Inserm specializing in medicine, pathology, and cell transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	373
2	Blood Transplantation	1	1	288
3	Genetic Medicine	1	1	85
4	Immunology	1	1	288
5	Marrow Transplantation	1	1	288

Céline Rodriguez

Publications

825

Citations

H-Index

Page 1

	Year	Citations
Postinduction Minimal Residual Disease Predicts Outcome and Benefit From Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia With<i>NPM1</i>Mutation: A Study by the Acute Leukemia French Association Group Marie Balsat, Aline Renneville, Xavier Thomas, Journal of Clinical Oncology Hematological MalignancyResidual DiseaseTransplantationMarrow TransplantationMedicine	2017	288
IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer Margaux Hubert, Élisa Gobbini, Coline Couillault, Science Immunology	2020	136
Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q Béatrice Orsetti, Mélanie Nugoli, Nathalie Cervera, British Journal of Cancer	2006	106
A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavage Colette Dezutter‐Dambuyant, Isabelle Durand, Laurent Alberti, OncoImmunology	2015	93
Niemann–Pick C disease: Use of denaturing high performance liquid chromatography for the detection of NPC1 and NPC2 genetic variations and impact on management of patients and families☆ Gilles Millat, Nathalie Baïlo, Sabine Molinero, Molecular Genetics and Metabolism Npc2 Genetic VariationsNiemann–pick C DiseaseMedicineInherited Metabolic DiseaseGenetic Epidemiology	2005	85
Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia Jean‐Emmanuel Bibault, Martin Figeac, Nathalie Hélevaut, Oncotarget	2015	53
The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers Aurélien Voissière, Carlos Gomez‐Roca, Sylvie Chabaud, Science Translational Medicine	2024	41
Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2 Candice Sakref, Alexis Saby, Céline Rodriguez, Nature Communications	2025	13
Second‐Generation CD73 Inhibitors Based on a 4,6‐Biaryl‐2‐thiopyridine Scaffold Rayane Ghoteimi, A. Braka, Céline Rodriguez, ChemMedChem	2023	10

Page 1